Many Insured Patients Still Can’t Afford Hearing Aids, Study Finds
-
By
-
May 13, 2025
-
6 min
By
May 13, 2025
A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.
April 23, 2026
by Xiaoxue Zhuo, Zhuoma Dangzeng, Peiyu Zhou, Tingting Wang, Lin Wang
April 21, 2026
A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.
by Kerri Miller
April 16, 2026